Claims Pared In Dey, Sepracor IP Fight Over Brovana
Sepracor Inc. and Dey LP have agreed to dismiss a range of individual patent claims in their battle over Sepracor's rollout of chronic obstructive pulmonary disease drug Brovana....To view the full article, register now.
Already a subscriber? Click here to view full article